DEPRESSIVE DISORDER, MAJOR
Clinical trials for DEPRESSIVE DISORDER, MAJOR explained in plain language.
Never miss a new study
Get alerted when new DEPRESSIVE DISORDER, MAJOR trials appear
Sign up with your email to follow new studies for DEPRESSIVE DISORDER, MAJOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Halted trial tests new drug to keep depression at bay
Disease control TerminatedThis study tested whether adding a new drug called aticaprant to standard antidepressants could help prevent depression from coming back in people who had recently gotten better. It focused on people whose depression includes a severe loss of interest and pleasure in life. The tr…
Matched conditions: DEPRESSIVE DISORDER, MAJOR
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for tough depression: drug plus therapy combo tested
Disease control TerminatedThis study aimed to see if combining a fast-acting depression medication (esketamine) with a specific talk therapy (behavioral activation) works better than the medication alone for people whose depression hasn't responded to other treatments. It involved a small group of adults …
Matched conditions: DEPRESSIVE DISORDER, MAJOR
Phase: NA • Sponsor: The Royal's Institute of Mental Health Research • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
New drug aims to restore joy for those whose depression resists treatment
Symptom relief TerminatedThis study tested whether adding an experimental drug called aticaprant to a person's current antidepressant could better treat major depression, specifically for people who struggle with severe anhedonia—the inability to feel pleasure. It involved 101 adults whose depression had…
Matched conditions: DEPRESSIVE DISORDER, MAJOR
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Symptom relief
Last updated Mar 24, 2026 12:02 UTC